Voya Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,038
| Closed | -$525K | – | 626 |
|
|
2021
Q1 | $525K | Buy |
4,038
+15
| +0.4% | +$1.95K | 0.02% | 416 |
|
|
2020
Q4 | $580K | Sell |
4,023
-21
| -0.5% | -$3.03K | 0.03% | 373 |
|
|
2020
Q3 | $452K | Buy |
4,044
+65
| +2% | +$7.27K | 0.02% | 389 |
|
|
2020
Q2 | $439K | Buy |
3,979
+269
| +7% | +$29.7K | 0.02% | 396 |
|
|
2020
Q1 | $289K | Sell |
3,710
-821
| -18% | -$64K | 0.02% | 449 |
|
|
2019
Q4 | $429K | Buy |
4,531
+256
| +6% | +$24.2K | 0.02% | 428 |
|
|
2019
Q3 | $327K | Buy |
4,275
+12
| +0.3% | +$918 | 0.02% | 467 |
|
|
2019
Q2 | $366K | Buy |
4,263
+109
| +3% | +$9.36K | 0.02% | 446 |
|
|
2019
Q1 | $369K | Buy |
4,154
+259
| +7% | +$23K | 0.02% | 433 |
|
|
2018
Q4 | $273K | Sell |
3,895
-8,159
| -68% | -$572K | 0.02% | 451 |
|
|
2018
Q3 | $1.16M | Buy |
12,054
+174
| +1% | +$16.7K | 0.07% | 222 |
|
|
2018
Q2 | $1.12M | Sell |
11,880
-2
| -0% | -$188 | 0.07% | 206 |
|
|
2018
Q1 | $1.03M | Sell |
11,882
-2
| -0% | -$174 | 0.07% | 226 |
|
|
2017
Q4 | $1.02M | Sell |
11,884
-732
| -6% | -$63.1K | 0.07% | 227 |
|
|
2017
Q3 | $1.08M | Buy |
12,616
+1,266
| +11% | +$109K | 0.07% | 219 |
|
|
2017
Q2 | $888K | Buy |
11,350
+737
| +7% | +$57.7K | 0.06% | 221 |
|
|
2017
Q1 | $740K | Buy |
10,613
+6,253
| +143% | +$436K | 0.06% | 232 |
|
|
2016
Q4 | $260K | Buy |
4,360
+1,301
| +43% | +$77.6K | 0.02% | 386 |
|
|
2016
Q3 | $200K | Buy |
+3,059
| New | +$200K | 0.02% | 419 |
|